We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Oric Pharmaceuticals
ORIC
$1.44B
| $14.6K | ﹤0.01% |
2,377
+25
| +1% | +$219 |
|
|
UHT
1427
Universal Health Realty Income Trust
UHT
$575M
| $14.5K | ﹤0.01% |
355
-12
| -3% | -$471 |
|
1428
Erasca
ERAS
$6.34B
| $14.4K | ﹤0.01% |
9,460
+39
| +0.4% | +$67 |
|
1429
Zevra Therapeutics
ZVRA
$667M
| $14K | ﹤0.01% |
1,786
+7
| +0.4% | +$56 |
|
|
SNDK
1430
Sandisk
SNDK
$226B
| $14K | ﹤0.01% |
+286
| New | +$14.2K |
|
|
CHCT
1431
Community Healthcare Trust
CHCT
$437M
| $13.9K | ﹤0.01% |
763
-20
| -3% | -$382 |
|
|
FPI
1432
Farmland Partners
FPI
$426M
| $13.8K | ﹤0.01% |
1,236
-41
| -3% | -$472 |
|
|
MESO
1433
Mesoblast
MESO
$2.14B
| $13.8K | ﹤0.01% |
1,138
+73
| +7% | +$1.2K |
|
|
IRBT
1434
DELISTED
iRobot
IRBT
| $13.8K | ﹤0.01% |
4,894
+433
| +10% | +$3.13K |
|
1435
Altimmune
ALT
$556M
| $13.7K | ﹤0.01% |
2,577
+207
| +9% | +$1.31K |
|
1436
CorMedix
CRMD
$611M
| $13.5K | ﹤0.01% |
2,010
-12
| -0.6% | -$124 |
|
1437
Cartesian Therapeutics
RNAC
$267M
| $13.4K | ﹤0.01% |
4,591
+29
| +0.6% | +$518 |
|
1438
IPG Photonics
IPGP
$3.64B
| $13.4K | ﹤0.01% |
205
-5
| -2% | -$336 |
|
1439
SIGA Technologies
SIGA
$208M
| $13.3K | ﹤0.01% |
2,389
+10
| +0.4% | +$59 |
|
|
BCYC
1440
Bicycle Therapeutics
BCYC
$281M
| $13.1K | ﹤0.01% |
1,464
-2
| -0.1% | -$24 |
|
1441
EyePoint Inc
EYPT
$1.15B
| $13.1K | ﹤0.01% |
2,251
-23
| -1% | -$161 |
|
|
ALX
1442
Alexander's
ALX
$1.4B
| $13.1K | ﹤0.01% |
62
-2
| -3% | -$405 |
|
|
BFS
1443
Saul Centers
BFS
$860M
| $12.9K | ﹤0.01% |
359
-11
| -3% | -$403 |
|
1444
Stoke Therapeutics
STOK
$2.09B
| $12.9K | ﹤0.01% |
1,787
+22
| +1% | +$205 |
|
1445
Sana Biotechnology
SANA
$1.1B
| $12.8K | ﹤0.01% |
7,471
+31
| +0.4% | +$87 |
|
1446
Regenxbio
RGNX
$702M
| $12.8K | ﹤0.01% |
1,631
-20
| -1% | -$149 |
|
|
RAPP
1447
Rapport Therapeutics
RAPP
$2.31B
| $12.7K | ﹤0.01% |
1,266
+47
| +4% | +$610 |
|
|
MRP
1448
Millrose Properties Inc
MRP
$5.01B
| $12.6K | ﹤0.01% |
+474
| New | +$11.1K |
|
|
LKFT
1449
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $12.4K | ﹤0.01% |
489
+24
| +5% | +$606 |
|
1450
Taysha Gene Therapies
TSHA
$1.95B
| $12.3K | ﹤0.01% |
6,372
-457
| -7% | -$764 |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.